Molecular Therapy: Methods & Clinical Development (Sep 2021)
Evidence generation and reproducibility in cell and gene therapy research: A call to action
- Mohamed Abou-el-Enein,
- Aris Angelis,
- Frederick R. Appelbaum,
- Nancy C. Andrews,
- Susan E. Bates,
- Arlene S. Bierman,
- Malcolm K. Brenner,
- Marina Cavazzana,
- Michael A. Caligiuri,
- Hans Clevers,
- Emer Cooke,
- George Q. Daley,
- Victor J. Dzau,
- Lee M. Ellis,
- Harvey V. Fineberg,
- Lawrence S.B. Goldstein,
- Stephen Gottschalk,
- Margaret A. Hamburg,
- Donald E. Ingber,
- Donald B. Kohn,
- Adrian R. Krainer,
- Marcela V. Maus,
- Peter Marks,
- Christine L. Mummery,
- Roderic I. Pettigrew,
- Joni L. Rutter,
- Sarah A. Teichmann,
- Andre Terzic,
- Fyodor D. Urnov,
- David A. Williams,
- Jedd D. Wolchok,
- Mark Lawler,
- Cameron J. Turtle,
- Gerhard Bauer,
- John P.A. Ioannidis
Affiliations
- Mohamed Abou-el-Enein
- Division of Medical Oncology, Department of Medicine and Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Joint USC/CHLA Cell Therapy Program, University of Southern California and Children’s Hospital Los Angeles, Los Angeles, CA, USA; Corresponding author: Mohamed Abou-el-Enein, Division of Medical Oncology, Department of Medicine and Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Aris Angelis
- Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK; Department of Health Policy and LSE Health, London School of Economics and Political Science, London, UK
- Frederick R. Appelbaum
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
- Nancy C. Andrews
- Department of Pharmacology and Cancer Biology and Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
- Susan E. Bates
- Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA
- Arlene S. Bierman
- Center for Evidence and Practice Improvement, Agency for Healthcare Research and Quality, Rockville, MD, USA
- Malcolm K. Brenner
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
- Marina Cavazzana
- Biotherapy Department, Necker Children’s Hospital, Assistance Publique-Hopitaux de Paris, Paris, France; Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Quest, INSERM, Paris, France
- Michael A. Caligiuri
- Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA, USA
- Hans Clevers
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, the Netherlands; University Medical Center Utrecht, Utrecht, the Netherlands
- Emer Cooke
- European Medicines Agency, Amsterdam, the Netherlands
- George Q. Daley
- Boston Children’s Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
- Victor J. Dzau
- US National Academy of Medicine, Washington, DC, USA
- Lee M. Ellis
- Department of Surgical Oncology and Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Harvey V. Fineberg
- Gordon and Betty Moore Foundation, Palo Alto, CA, USA
- Lawrence S.B. Goldstein
- Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- Stephen Gottschalk
- Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN, USA
- Margaret A. Hamburg
- American Association for the Advancement of Science (AAAS), Washington, DC, USA; National Academy of Medicine, Washington, DC, USA
- Donald E. Ingber
- Boston Children’s Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA
- Donald B. Kohn
- Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; The Eli & Edith Broad Center of Regenerative Medicine & Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, USA
- Adrian R. Krainer
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
- Marcela V. Maus
- Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA
- Peter Marks
- Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
- Christine L. Mummery
- Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands
- Roderic I. Pettigrew
- ENMED, Colleges of Medicine and Engineering, Texas A&M University, Houston, TX, USA
- Joni L. Rutter
- National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
- Sarah A. Teichmann
- Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; Theory of Condensed Matter, Cavendish Laboratory, University of Cambridge, JJ Thomson Ave, Cambridge, UK
- Andre Terzic
- Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
- Fyodor D. Urnov
- Innovative Genomics Institute, University of California, Berkeley, CA, USA
- David A. Williams
- Boston Children’s Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA
- Jedd D. Wolchok
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- Mark Lawler
- Patrick G Johnston Centre for Cancer Research, Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast, Belfast, UK
- Cameron J. Turtle
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
- Gerhard Bauer
- Institute for Regenerative Cures, University of California, Davis, Sacramento, CA, USA
- John P.A. Ioannidis
- Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA, USA; Department of Epidemiology and Population Health and Department of Biomedical Data Sciences, Stanford University, Stanford, CA, USA
- Journal volume & issue
-
Vol. 22
pp. 11 – 14